Switch to:
More From Other Websites
Incyte Teams Up With Dow's Merck To Trounce Roche In Cancer May 18 2017
Biotech Stocks: Is ASCO Much Ado About Nothing? May 18 2017
Data from Clinical Study of NewLink Genetics’ IDO Pathway Inhibitor, Indoximod, to Be Presented at... May 18 2017
Data from Clinical Studies of NewLink Genetics’ Two Distinct IDO Pathway Inhibitors to Be... May 17 2017
Newman Ferrara LLP Announces Corporate Governance Investigation of NewLink Genetics Corporation -... May 15 2017
ETFs with exposure to NewLink Genetics Corp. : May 11, 2017 May 11 2017
NewLink Genetics Corp. :NLNK-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 May 09 2017
NewLink Genetics to Participate in Upcoming Investor Conferences May 08 2017
3 Intriguing Cancer Drugs With Data Coming at ASCO Next Month May 05 2017
NewLink reports 1Q loss May 04 2017
NewLink Genetics Reports First Quarter 2017 Financial Results and Updates Clinical Trial Guidance May 04 2017
Investor Network: Newlink Genetics Corporation to Host Earnings Call May 04 2017
Lifshitz & Miller LLP Announces Investigation of Bingo Nation Inc., BofI Holding, Inc., Corbus... May 03 2017
Vaunted Ebola Vaccine Faces Questions Apr 24 2017
NewLink Genetics Corp. – Value Analysis (NASDAQ:NLNK) : April 21, 2017 Apr 21 2017
Should Gilead Sciences Acquire NewLink Genetics? Apr 21 2017
NewLink Genetics Announces Presentation of Two Abstracts at ASCO Apr 21 2017
NewLink Genetics Corp. breached its 50 day moving average in a Bullish Manner : NLNK-US : April 20,... Apr 20 2017
Morgan Stanley Ups Incyte Target to $150 Apr 13 2017
The IDO-Inhibitor Race Is On to Improve Cancer Treatment Apr 13 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK